We are live on ! Find out more
INSM icon

Insmed

226 hedge funds and large institutions have $2.87B invested in Insmed in 2022 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 102 increasing their positions, 61 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more capital inflows, than outflows

Capital inflows: $483M | Capital outflows: $186M

67% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 61

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

0.15% less ownership

Funds ownership: 106.17% → 106.01% (-0.15%)

2% less call options, than puts

Call options by funds: $3.22M | Put options by funds: $3.29M

5% less funds holding

Funds holding: 239 → 226 (-13)

30% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 44

Holders
226
Holders Change
-13
Holders Change %
-5.44%
% of All Funds
3.62%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
31
Increased
102
Reduced
61
Closed
44
Calls
$3.22​M
Puts
$3.29​M
Net Calls
-⁠$72​K
Net Calls Change
-⁠$1.87​M

INSM Hedge Fund Activity: Q4 2022 in Review

226 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2022, worth a combined $2.87B — up 4.6% from $2.74B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of INSM and 31 opened new positions — a net loss of 13 holders — while 61 trimmed existing stakes and 102 added.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $82.4M. The largest seller was Fairmount Funds Management, exiting entirely with an estimated $28.8M sold.

  • 226 institutional investors held Insmed (INSM) as of Q4 2022, down from 239 in Q3 2022.
  • Funds reported $2.87B of Insmed stock for Q4 2022, up 4.6% quarter-over-quarter.
  • 31 funds opened new Insmed positions in Q4 2022 and 44 closed out, a net change of -13 holders.
  • The largest Insmed buyer in Q4 2022 was Deep Track Capital, an estimated $82.4M added.
  • The largest Insmed seller in Q4 2022 was Fairmount Funds Management, an estimated $28.8M sold.

Based on aggregated 13F filings for Q4 2022.